Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Amit

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 23, 2022
Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trialJason G Andrade, Laurent Macle, Matthew T Bennett, et al.
Global Cardiology Science & Practice|January 19, 2016
Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and designHisham Dokainish, Esam Elbarasi, Simona Masiero, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 28, 2020
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysisMariëlle Kloosterman, Jonas Oldgren, David Conen, et al.
The New England Journal of Medicine|November 7, 2022
Progression of Atrial Fibrillation after Cryoablation or Drug TherapyJason G Andrade, Marc W Deyell, Laurent Macle, et al.
The Canadian Journal of Cardiology|March 11, 2019
Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device ImplantationCaroline M Van De Heyning, Esam Elbarasi, Simona Masiero, et al.
Cell|September 30, 2022
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactionsLian Narunsky-Haziza, Gregory D Sepich-Poore, Ilana Livyatan, et al.
Annals of Internal Medicine|November 7, 2022
Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations : A Randomized, Multicenter TrialJeff S Healey, Andrew D Krahn, Jamil Bashir, et al.
The New England Journal of Medicine|November 10, 2025
Antithrombotic Therapy after Successful Catheter Ablation for Atrial FibrillationAtul Verma, David H Birnie, Chenyang Jiang, et al.
The New England Journal of Medicine|November 18, 2024
Catheter Ablation or Antiarrhythmic Drugs for Ventricular TachycardiaJohn L Sapp, Anthony S L Tang, Ratika Parkash, et al.
Journal of the American College of Cardiology|July 17, 2024
Apixaban vs Aspirin According to CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiARenato D Lopes, Christopher B Granger, Daniel M Wojdyla, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 23, 2022
Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trialJason G Andrade, Laurent Macle, Matthew T Bennett, et al.
Global Cardiology Science & Practice|January 19, 2016
Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and designHisham Dokainish, Esam Elbarasi, Simona Masiero, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 28, 2020
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysisMariëlle Kloosterman, Jonas Oldgren, David Conen, et al.
The New England Journal of Medicine|November 7, 2022
Progression of Atrial Fibrillation after Cryoablation or Drug TherapyJason G Andrade, Marc W Deyell, Laurent Macle, et al.
The Canadian Journal of Cardiology|March 11, 2019
Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device ImplantationCaroline M Van De Heyning, Esam Elbarasi, Simona Masiero, et al.
Cell|September 30, 2022
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactionsLian Narunsky-Haziza, Gregory D Sepich-Poore, Ilana Livyatan, et al.
Annals of Internal Medicine|November 7, 2022
Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations : A Randomized, Multicenter TrialJeff S Healey, Andrew D Krahn, Jamil Bashir, et al.
The New England Journal of Medicine|November 10, 2025
Antithrombotic Therapy after Successful Catheter Ablation for Atrial FibrillationAtul Verma, David H Birnie, Chenyang Jiang, et al.
The New England Journal of Medicine|November 18, 2024
Catheter Ablation or Antiarrhythmic Drugs for Ventricular TachycardiaJohn L Sapp, Anthony S L Tang, Ratika Parkash, et al.
Journal of the American College of Cardiology|July 17, 2024
Apixaban vs Aspirin According to CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiARenato D Lopes, Christopher B Granger, Daniel M Wojdyla, et al.
Pageof 12